See below for Disclaimer, information on Copyright, and Disclosures.
The information presented on this site is provided for education and informational purposes.
Any opinions expressed on this site are entirely my own and are based on my personal experiences and my interpretations of data.
I am not a physician or medical care provider and any opinions or statements expressed here should not be interpreted as personal medical advice.
I have made all reasonable attempts to provide accurate information but I do not assume any responsibility for errors or omissions. Please contact me should you feel you have identified any such inaccuracies. Note that posts on the site are not usually updated and reflect current information as of the time of the original posting.
All content on this site is original unless otherwise noted, © 2018 vasculitides.com, all rights reserved. Original content on the site may be freely used for personal, educational, or non-commercial purposes unless otherwise noted. If you do share or use any original content posted on this site, please attribute vasculitides.com as the source and link back to the site.
In the interest of transparency, below are disclosures of my relationships with any entities which could be a potential source of conflict of interest or bias related to any content posted on this site. Disclosures will be noted on individual posts, with more detailed information describing the nature of the potential conflicts or biases described below.
Patient in GSK-sponsored clinical trial for mepolizumab. I was a patient in the first clinical trial testing mepolizumab in EGPA/Churg-Strauss patients between March 2015 to May 2016. The trial was funded by GSK, the manufacturer of mepolizumab. I was randomized to the placebo control group but later received this drug through a long term access program sponsored by GSK. I am still currently taking this drug. I received financial compensation for monthly study visits totalling less than $1,000 during the fourteen months of the trial and I donated these funds to the non-profit Vasculitis Foundation.
V-PPRN patient-partner. I am a patient-partner, without financial compensation, for the Vasculitis Patient Powered Research Network (V-PPRN) funded by PCORI (2017-present).
EGPA/Churg-Strauss educational/awareness video for GSK. In April of 2018, I participated in filming of educational material promoting awareness of EGPA/Churg-Strauss for GSK, the manufacturer of mepolizumab. I received financial compensation totalling less than $1,000 for my participation and I donated these funds to the non-profit Vasculitis Foundation.
Biomedical researcher. In my professional life, I have a Ph.D. in Pathology, I work as a biomedical researcher at a major medical institution, and I am funded by grants received from the National Institutes of Health (NIH), all of which may lead me to have a bias toward evidence-based medicine.